Sen. Grassley says probe of 'secretive' drug industry pricing won't stop with drugmakers

Senate Finance Committee Chairman Chuck Grassley says drug prices are set in "a great deal of secrecy," and there needs to be more transparency.

from Health and Science https://ift.tt/2TnkPci